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Epidemiological reports have suggested that the consumption of foods rich in ﬂavonoids is associated
with a lower incidence of certain degenerative diseases, including cardiovascular disease. Flavanols and
their related oligomers, the procyanidins CFP, isolated from cocoa can modulate the production and
level of several signaling molecules associated with immune function and inﬂammation in vitro,
including several cytokines and eicosanoids. To further elucidate the potential immuno-modulatory
functions of ﬂavanol-rich cocoa, the present investigation examined whether isolated CFP fractions
(monomers through decamers) inﬂuence the secretion of tumor necrosis factor-a (TNF-a) from resting
and phytohemagluttinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC).
Weused aninvitro culture system where PBMCfrom 14 healthy subjects were introduced toindividual
CFP fractions for 72h prior to measuring the levels of TNF-a released. The intermediate-sized CFP
fractions (tetramers through octamers) were the most active on resting cells, causing a 3–4 fold
increase in TNF-a relative to media baseline. The monomers and dimers were the least stimulatory of
the fractions tested, displaying a 42 and 31% increase, respectively, over media control, whereas the
trimers, nonamers and decamers showed an intermediate stimulation of this cytokine. In the presence of
PHA, the intermediate-sized CFP fractions again were the most active, enhancing TNF-a secretion in
the range of 48–128% relative to the PHA control. The monomers and dimers were slightly inhibitory
(21.5 and 215%, respectively), while trimers, nonamers and decamers stimulated moderate increases
in TNF-a levels (13, 19 and 15%, respectively). The above results lend support to the concept that CFP
can be immunomodulatory. The stimulation of TNF-a secretion may contribute to the putative
beneﬁcial effects of dietary ﬂavanoids against microbial infection and tumorigenesis.
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INTRODUCTION
Cocoa and its derivative products, such as chocolate, have
recently garnered considerable scientiﬁc attention, in part
becausetheycanberichincertainﬂavanoids.Inparticular,
ﬂavanol subclass, including (2)-epicatechin, (þ)-cate-
chin and their related oligomers, the procyanidins CFP,
can be abundant in cocoa and chocolate products (Fig. 1)
(Hammerstone et al., 1999; Lazarus et al., 1999). The
presence of ﬂavonoids in notable concentrations in certain
foods (e.g. select fruits, vegetables and legumes) has
triggered numerous studies on their potential health
beneﬁts, and accumulating epidemiological evidence
suggests that consumption of ﬂavonoid-rich foods and
beverages are associated with a reduced risk of
cardiovascular disease and certain cancers (Rice-Evans
et al., 1995; Stoner and Mukhtar, 1995; Holt et al. 2002a;
Kris-Etherton and Keen, 2002). While cocoa contains a
complex mixture of CFP, only the monomeric ﬂavanols
and small amounts of the procyanidin dimers have been
measured in blood following consumption (Rein et al.,
2000; Wang et al., 2000; Baba et al., 2001; 2002; Holt
et al., 2002b; Steinberg et al., 2002). Limited information
is available concerning the absorption and metabolism of
the larger cocoa procyanidins; however, a signiﬁcant
fraction of these procyanidins ($ trimers) appear to reach
the upper intestine intact following the consumption of a
CFP-enriched meal (Rios et al., 2002).
Recently, select CFP have demonstrated activity invivo
and in vitro that is suggestive of potential cardiovascular
beneﬁts. The focus of this research has generally centered
around the concept that CFP-rich foods might improve
tissue oxidant defense systems (Rice-Evans et al., 1995;
Kris-Etherton and Keen, 2002), reduce platelet reactivity
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and improve vascular health by inducing vascular
relaxation (Arteel and Sies, 1999; Stein et al., 1999;
Karim et al., 2000; Duffy et al., 2001). The mechanisms
responsible, at least in part, for CFP-induced increases in
endothelium-dependent relaxation are thought to involve
the modulation of nitric oxide (NO) (Arteel and Sies,
1999; Karim et al., 2000) and select eicosanoid levels
(Schramm et al., 2001; Holt et al., 2002a; Schewe et al.,
2002), as well as the augmentation of select arms of the
oxidant defense system (Rice-Evans et al., 1995; 1996;
Bagchi et al., 1997; Virgili et al., 1998; Arteel and Sies,
1999; Lotito et al., 2000; Wang et al., 2000; Pearson et al.,
2001; Kris-Etherton and Keen, 2002; Zhu et al., 2002).
Complementing the above, we have demonstrated that
distinct CFP fractions have the potential to modulate the
production of several immunomodulatory cytokines.
Under similar in vitro culture settings, select CFPs were
shown to effectively suppress the production of cytokines
(IL-1b and IL-2) that promote inﬂammation (Mao et al.,
1999; 2000a,b) while increasing the release of anti-
inﬂammatory cytokines (IL-4 and IL-5) (Mao et al.,
2000c; 2002). Interestingly, CFP had a differential effect
on the peripheral blood mononuclear cells (PBMC)
production of TGF-b1, depending on the constitutive
production of the cytokine (Mao et al., 2003). Tumor
growth factor-b1 can beneﬁt the cardiovascular system by
actively maintaining the normal physiological phenotype
of endothelial cells and smooth muscle cells in the arterial
vessel wall (Grainger, 1997). However, excess production
of TGF-b1 can cause extracellular matrix accumulation
that is unfavorable for injured vessel wall, which can
consequently lead to cardiac ﬁbrosis (Lijnen et al., 2000).
We observed that the PBMC isolated from individuals
with low baseline levels of TGF-b1 were stimulated by
individual fractions to enhance secretion, whereas
production from PBMC isolated from high baseline
producers was inhibited by the cocoa procyandins and
ﬂavanols (Mao et al., 2003). The above results suggest
that CFP can have differential effects in the production of
certain cytokines depending on the immunological status
of the individual. In a separate study, we reported that
smaller CFPs may contribute to the health of the oral
cavity by augmenting the mitogen-induced secretion of
IL-5 (Mao et al., 2002). Interleukin-5, as an integral
cytokine, is responsible for mediating the production of
IgA, and thus conferring protection against periodontitis
(Kinane et al., 1999; Salvi and Holgate, 1999). In the
current investigation, we wanted to extend our existing
knowledge of the immuno-modulatory potential of CFP to
their effects on the production of tumor necrosis factor-
alpha (TNF-a) from human PBMC.
MATERIALS AND METHODS
Cocoa Fraction Preparation
Water soluble CFP fractions were prepared from
Cocoaproe cocoa and quantiﬁed by LC-MS as detailed
by Adamson et al. (1999), and were provided by Mars,
Incorporated (Hackettstown, NJ). The monomers fraction
contained the ﬂavan-3-ols, (2)-epicatechin and (þ)
catechin. Puriﬁed oligomers (dimers through decamers)
of these monomeric procyanidins were investigated
(Fig. 1). The puriﬁed CFP fractions contained less than
0.5% (w/w) of total alkaloids (theobromine and caffeine).
The monomer and procyanidin composition, estimated by
HPLC and molecular weights of these preparations are
shown in Table I. All samples were suspended in RPMI
1640 (Invitrogen Corp., Carlsbad, CA) with 10%
heat inactivated fetal bovine serum (Atlanta Bio-
logicals, Norcross, GA). They were then diluted
with the same medium to ﬁnal concentrations of
FIGURE 1 Chemical structures of the most common ﬂavan-3-ol monomers and procyanidins (dimers to decamers) in cocoa.
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in this study on prior dose response analysis conducted by
our laboratory and others assessing the impact of these
compounds on cytokine production and release (Sanbongi
et al., 1997; Mao et al., 1999; 2000a,b,c; 2002).
PBMC Isolation
Peripheral blood from healthy volunteers was collected
into sodium citrate-containing tubes and mixed 1:1 with
Hanks’ Balanced Salt Solution (HBSS; Invitrogen)
without calcium chloride, magnesium chloride or
magnesium sulfate. The diluted blood was then layered
over a Histopaque
w-1077 gradient (Sigma, St Louis, MO)
and centrifuged at 500g for 30min at room temperature.
PBMC were harvested from the interface layer, washed
twice with HBSS and then counted. The cells were
resuspended in RPMI 1640 containing 10% fetal bovine
serum and supplemented with 0.1% of a 50mg/ml
gentamicin solution (Invitrogen). PBMC concentration
was adjusted to 2 £ 106 viable cells/ml after estimation of
viability by trypan blue exclusion assay. Viability was
consistently greater that 96%.
Culture of PBMC with Cocoa FP Fractions
Five hundred microliters of a 1:0 £ 106 cell suspension
were cultured with equal volumes of the various CFP
treatments at 378C with 5% CO2 in 48-well plates. Resting
PBMC were incubated with individual CFP fractions at
25mg/ml in the presence or absence of PHA at 25mg/ml.
All treatments were performed in duplicate. Following a
72h incubation, the supernatant fractions were harvested
for ELISA analysis.
TNF-a (ELISA)
Culture supernatant fractions were harvested after 72h
and stored at 2208C until analysis by ELISA. Ninety-six
well Costar EIA plates (Cat. #2592) were coated with
mouse anti-TNF-a supplied in the DuoSet Human TNF-a
ELISA Development Kit (R and D Systems, Minneapolis,
MN). Supernates were measured for TNF-a concen-
trations according to the manufacturers’ recommen-
dations. The lowest TNF-a standard for the ELISA
system was 15.6pg/ml.
Statistics
The effects of different CFP fractions on the secretion of
TNF-a were examined in unstimulated resting PBMC.
Results were compared by Student paired t-test with a
two-tailed p-value (i.e. control cells without CFP vs. cells
treated with individual CFP fractions). Signiﬁcance was
taken as p , 0:05:
RESULTS
Unstimulated resting PBMC were prepared and incubated
with individual CFP fractions at 25mg/ml. TNF-a
production was then assessed in the supernatant fractions
following a 72h incubation period. ELISA analysis
revealed that the CFP were stimulatory for the secretion of
TNF-a, regardless of the degree of oligomerization
(Fig. 2). The monomeric and dimeric fractions were the
least stimulatory of the group of fractions tested,
displaying 42 and 31% increases, respectively, over
media baseline level ð315 ^ 96pg=mlÞ (Table II). The
intermediate-sized procyanidins (tetramers through octa-
mers) induced a marked 3–4 fold increase over media
baseline (Table II). At levels between the two extremes,
the trimeric, nonumeric and decameric fractions stimu-
lated the release of TNF-a approximately two fold over
baseline control (Table II).
In the second part of this study, the effects of CFP on the
production of TNF-a by stimulated PBMC were
investigated. In a similar in vitro culture system, the
CFP treated cells, at the same concentration (25mg/ml) as
described above, were co-incubated with PHA at 25mg/ml
for 72h prior to the harvest of supernates. Phytohemag-
glutinin, a mitogen known to stimulate CD4
þ TH1 and
CD8
þ T cells, caused a marked increase in TNF-a
secretion ð2668 ^ 318pg=mlÞ from PBMC in comparison
to unstimulated media control ð315 ^ 96pg=mlÞ: In PHA-
stimulated PBMC, the CFP fractions displayed similar
patterns of response to that observed in the resting cells
(Fig. 3). In particular, the intermediate-sized fractions
(tetramers through octamers) were able to signiﬁcantly
enhance the level of TNF-a secretion in the range of
48–128% over the PHA control (Table II). Consistent
with the CFP effects observed in resting PBMC, the
trimeric, nonumeric and decameric fractions induced
moderate increases of 13–19% over the PHA control in
stimulated cells. In contrast to the higher molecular weight
fractions, the monomeric and dimeric cocoa fractions
suppressed the PHA-induced response by 1.5 and 15%,
respectively.
TABLE I Proﬁle of the individual cocoa FP fractions
Fraction name Molecular weight (Da) Procyanidin proﬁle %
Monomers 290 Monomers 95
Dimers 578 Dimers 98
Trimers 866 Trimers 93
Tetramers 1154 Tetramers 93
Pentamers 1442 Pentamers 93
Hexamers 1730 Hexamers 89
Heptamers 2018 Heptamers 79
Hexamers 18
Octamers 2306 Octamers 76
Heptamers 16
Nonamers 2594 Nonamers 60
Octamers 28
Decamers 2882 Decamers 40
Nonamers 17
Octamers 22
Heptamers 16
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The appealing association of a diet rich in ﬂavanols with a
variety of health beneﬁts has sparked numerous studies to
corroborate the epidemiological ﬁndings. A number of
investigations have shown that ﬂavanols, including those
derived from cocoa seeds, display antioxidant activities
(Rice-Evans et al., 1995; Rice-Evans et al., 1996; Bagchi
et al., 1997; Virgili et al., 1998; Pearson et al., 2001;
Kris-Etherton and Keen, 2002), as well as the ability to
modulate the levels of eicosanoids, NO and peroxynitrite
(Arteel and Sies, 1999; Schramm et al., 2001; Schewe
et al., 2002). Complementary to the properties suggested
above, we have demonstrated that select CFP fractions can
modulate the production of cytokines associated with
inﬂammation (IL-1b, IL-2 and IL-4) (Mao et al., 1999;
2000a,b,c), vascular health (TGF-b1) (Mao et al., 2003),
and oral cavity health (IL-5) (Mao et al., 2002). Here, we
have extended these ﬁndings to evaluate the effect of CFP
monomers to decamers on the production of TNF-a.
In the present study, we have shown that the
intermediate-sized CFP fractions (tetramers to octamers)
can signiﬁcantly augment the release of TNF-a from
unstimulated, and mitogen-induced human PBMC, while
the monomeric and dimeric fractions proved to be only
moderately stimulatory in resting cells, and slightly
inhibitory in the presence of PHA. It has been previously
shown that mitogen-stimulated human PBMC displayed
optimum TNF-a levels at 24h, and that the levels
steadily decline following this timepoint (Feldman et al.,
1999). Since our measurements were taken at 72h post-
exposure, it is possible that the levels observed with our
current protocol are signiﬁcantly diminished. Indeed, the
inhibition displayed by the monomeric and dimeric
CFP fractions with PHA-stimulated PBMC might be
TABLE II Effect of cocoa FP fractions on TNF-a secretion in
unstimulated ðn ¼ 10Þ and PHA-stimulated ðn ¼ 14Þ PBMCs. In each
group, the mean values from cocoa treated samples are compared to
corresponding mean baseline values and expressed as percent change
from media and PHA baseline controls. The levels of TNF-a secretion in
pg/ml are indicated in parenthesis (mean ^ SEM)
FP fraction Unstimulated PBMCs PHA-stimulated PBMCs
Controls Media (315 ^ 96) PHA (2668 ^ 318)
Monomers + 42% (447 ^ 109) 2 1.5% (2628 ^ 289)
Dimers + 31% (414 ^ 112) 2 15% (2259 ^ 264)
Trimers + 184% (895 ^ 243) + 13% (3028 ^ 471)
Tetramers + 320% (1324 ^ 326) + 64% (4382 ^ 612)
Pentamers + 384% (1525 ^ 262) + 116% (5774 ^ 725)
Hexamers + 412% (1614 ^ 227) + 128% (6086 ^ 783)
Heptamers + 295% (1243 ^ 267) + 61% (4292 ^ 676)
Octamers + 338% (1381 ^ 199) + 48% (3952 ^ 522)
Nonamers + 244% (1083 ^ 146) + 19% (3166 ^ 384)
Decamers + 183% (890 ^ 179) + 15% (3080 ^ 490)
FIGURE 2 The effect of cocoa FP on secretion of TNF-a from unstimulated PBMC. PBMC were incubated with individual cocoa fractions (25mg/ml)
for 72h before supernates were extracted for ELISA analysis (mean ^ SEM; n ¼ 10). Values induced from cocoa treatment were compared with control
values (i.e. media baseline without cocoa) using a Student paired t-test with a two-tailed p-value. *Signiﬁcance was taken as p , 0:05:
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TNF-a secretion during early exposure.
Although ﬂavanols, a subgroup of compounds belong-
ing to the ﬂavanoid family, are found in both cocoa and
tea, there are signiﬁcant structural differences, not to
mention the catechin content of chocolate can be four
times that of tea (Arts et al., 1999). The predominant
catechins found in tea are (2)-epicatechin gallate and
(2)-epigallocatechin gallate (EGCG), with EGCG
accounting for greater than 40% of the total polyphenols
(Hara, 1997). Several groups have reported that EGCG
can inhibit TNF-a production at both the transcriptional
and protein levels by blocking nuclear transcription
factor-kB (NF-kB) in rat and murine models (Yang et al.,
1998; Fujiki et al., 1999; Suganuma et al., 2000; Yang
et al., 2001). Interestingly, when EGCG was added to a
murine alveolar macrophage cell line (MH-S) pretreated
with nicotine, EGCG diminished the nicotine-induced
suppression of TNF-a production (Matsunaga et al.,
2002). However, in another study utilizing human
leukocytes, EGCG had no effect on the production of
TNF-a (Crouvezier et al., 2001).
TNF-a is a proinﬂammatory cytokine with numerous
biological functions critical for response to infections.
A pivotal role of TNF-a is its ability to activate, and
subsequently to enhance, the antimicrobial and tumor-
icidal activities of macrophages. In a previous study, we
reported that the pentameric through decameric CFP
fractions can be stimulatory for another proinﬂammatory
cytokine, IL-1b, in the presence and absence of PHA
(Mao etal.,2000a).Taken together with our present study,
it is evident that under some circumstances, the larger
cocoa CFP fractions ($ pentamer) can be proinﬂamma-
tory, triggering high production of IL-1b and TNF-a
relative to controls.
The mechanism(s) by which CFP modulate cytokine
production are unclear. However, eicosanoids have been
postulated to play a pivotal role in the regulation of
TNF-a gene expression (Jongeneel, 1994). Prostagland-
ins and leukotrienes are known to have antagonistic
effects with the downregulation of TNF-a production
attributed to prostaglandins (Jongeneel, 1994). Inhibi-
tion of cyclooxygenase (COX) and lipoxygenase, key
enzymes in the biosythesis of prostaglandins and
leukotrienes, respectively, will in turn alter TNF-a
levels (Jongeneel, 1994). Recently, it has been shown
that (þ)-catechin can inhibit COX activity (Noreen
et al., 1998). Therefore, it is plausible that the TNF-a
stimulation observed with our monomeric fraction is, in
part, due to the presence of (þ)-catechin interfering
with the normal negative feedback loop mediated by
prostaglandins (Jongeneel, 1994). Alternatively, it has
recently been shown that CFP, particularly (2)-
epicatechin and the procyanidin dimers, can display
signiﬁcant inhibition of 5-lipoxygenase, whereas the
trimeric through pentameric fractions show intermediate
suppression, and the larger procyanidins (hexamers
through nonamers) are relatively inactive (Schewe et al.,
2002). This observation is consistent with the present
analysis in which the monomer and dimer fractions
were the least stimulatory when compared with the
larger procyanidins.
As alluded to above, there is currently no consensus
concerning the effects of ﬂavonoids on the production of
FIGURE 3 The effect of cocoa FP on secretion of TNF-a from PHA-stimulated PBMC. PBMC were incubated with individual cocoa fractions
(25mg/ml) in the presence of PHA (25mg/ml) for 72h before supernates were extracted for ELISA analysis (mean ^ SEM; n ¼ 14). Values induced
from cocoa treatment were compared with control values (i.e. media baseline without cocoa) using a Student paired t-test with a two-tailed p-value.
*Signiﬁcance was taken as p , 0:05:
COCOA AND TNF-a 139TNF-a. In one study, it was shown that monomeric and
dimeric procyanidins inhibited TNF-a release from
murine RAW 264.7 macrophages, while the trimeric
fraction enhanced secretion (Park et al., 2000). Wine
polyphenols also displayed different effects on cytokine
production. Whereas quercetin decreased the LPS-
stimulated release of TNF-a from RAW 264.7 macro-
phages, resveratrol augmented production (Wadsworth
and Koop, 1999). Clearly, the discrepancy in these invitro
studies lies in the structure of plant polyphenols and their
degree of polymerization, as well as the type of cells that
are being exposed to these compounds in an in vitro
setting. Nevertheless, our analysis suggests that incuba-
tion of human PBMC with CFP fractions not only
modulates the production of TNF-a, but can signiﬁcantly
upregulate the synthesis and secretion of this pro-
inﬂammatory cytokine. In summary, this investigation
implicates that CFP may provide thearapeutic protection
against certain microbial infections and tumorigenesis.
Given the bioavailability of the CFP compounds, it can be
speculated that the higher oligomers will primarily exert
effects in the gastrointestinal tract. The relatively
moderate effect of the monomers and dimers on TNF-a
production suggests that they would have minimal effects
on cardiovascular health with respect to TNF-a pathways.
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